Source
Author: unknown
Eli Lilly to buy genetic medicine developer Akouos for $487 million [Deals Market Headlines | Breaking Stock Market News | Reuters]
Related Posts
UK Private Hospital Giant Spire Agrees to £1.03 Billion Buyout Led by Toscafund
Spire Healthcare Group agreed on September 5, 2026, to a £1.03 billion cash takeover by Tulip UK Bidco, an investment consortium led by hedge fund manager Toscafund Asset Management alongside THCP...
AbbVie Solidifies Immunology Dominance with $10.9 Billion Acquisition of Apogee Therapeutics
AbbVie (NYSE: ABBV) today announced the successful completion of its acquisition of Apogee Therapeutics (NASDAQ: APGE), an all-cash transaction valued at approximately $10.9 billion. Under the terms...
Lilly Adds to Immune Drug Pipeline with $2.9B Merida Buyout
In a strategic maneuver to solidify its presence beyond the metabolic health sector, Eli Lilly and Company (NYSE: LLY) announced on August 31, 2026, a definitive agreement to acquire Merida...
Curium Strikes $8 Billion Mega-Deal for Lantheus to Forge Global Radiopharmaceutical Powerhouse
In a definitive move to dominate the rapidly expanding nuclear medicine landscape, Curium US Holdings has entered into a definitive agreement to acquire Lantheus Holdings, Inc. (NASDAQ: LNTH) for a...